Loading viewer...
other
Format: PDF other
Gavi's evidence-based Vaccine Investment Strategy (VIS) 2024 outlines immunization priorities and vaccine investments for the 2026–2030 strategic cycle. The strategy employs transparent methodology, analytic review, and expert consultation to identify 19 infectious diseases and evaluate emerging epidemic threats, while providing predictability for vaccine developers, governments, and donors.
other
22 Pages
Gibson Dunn
Amadeus IT Group New Segment Reporting 2021
otherother
22 Pages
Amadeus IT Group
other
27 Pages
ΤΙΤΑΝ
<UNKNOWN>
otherother
73 Pages
Unknown
Resideo Technologies Proxy Statement Schedule 14A
otherother
77 Pages
Resideo Technologies